H2-gamendazole (H2-GMZ): a new therapeutic lead for treatment of polycystic kidney disease

* Corresponding Author; email: [email protected]

1Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, United States

3Lewis Katz School of Medicine, Department of Cancer and Cellular Biology, Philadelphia, PA, United States

* Corresponding Author; email: [email protected]

Search for more papers by this author

留言 (0)

沒有登入
gif